FDA approves topical treatment addressing repigmentation in vitiligo in patients aged 12 and older

Retrieved on: 2022-07-19 18:06:24

Tags for this article:

Click the tags to see associated articles and topics

FDA approves topical treatment addressing repigmentation in vitiligo in patients aged 12 and older. View article details on hiswai:

Excerpt

Satisfactory patient response may require treatment with Opzelura for more ... In people with vitiligo, the immune system appears to attack the ...

Article found on: www.fda.gov